
Welcome to part six of our summer education series.
If there is one area where estheticians can dramatically expand their value to clients, it is understanding and acknowledging the role hormones play in skin health. Most of our clients are walking around with skin that is being shaped, in real time, by hormonal forces they don't fully understand and have rarely had explained to them. They blame their products, genetics or maybe even you.
The truth is, hormones are running more of the show than almost any other variable. Estrogen, progesterone, androgens, cortisol, insulin, thyroid hormones, growth hormone — each of these is shaping the skin in specific ways.
To add to the complexity, hormones changes across our lifespan, and a client at twenty-five, thirty-eight, forty-six, and fifty-eight is essentially four different skin systems. Treating them all with the same playbook is one of the most common reasons protocols fail.
The skin is not a passive target — it is an endocrine organ
Before we get into specific hormones, it is worth understanding something that often goes unstated: the skin is not just on the receiving end of hormonal activity. It actively participates.
Skin cells produce, metabolize, and respond to hormones locally. Sebaceous glands, hair follicles, sweat glands, keratinocytes, fibroblasts, and immune cells all express hormone receptors. The skin can even convert precursor hormones into active forms, and the local hormonal environment can differ meaningfully from what shows up on a blood test.
This is why some clients with apparently normal lab values still present with hormonally-driven skin issues. The skin can be reacting to hormones it is producing or metabolizing locally, independent of systemic measurements. When a client tells you "my labs came back fine but my skin is clearly hormonal," they are not imagining things. The biology supports them.
Estrogen
Estrogen is the dominant hormone for skin health in women of reproductive age. It supports nearly every structural and functional quality we associate with youthful, healthy skin.
Estrogen stimulates collagen production and slows collagen breakdown. It supports hyaluronic acid synthesis. It maintains skin thickness. It supports barrier function through effects on lipid synthesis. It contributes to vascular tone and skin pinkness. It even influences wound healing speed and quality.
When estrogen drops — as it does dramatically in perimenopause and menopause — the skin loses its primary structural support. The numbers here are striking and worth knowing precisely: research has consistently shown that women lose approximately 30% of their dermal collagen in the first five years after menopause, followed by an ongoing decline of roughly 2.1% per year for the next 15 years. Skin thickness decreases at a similar rate.
Here is maybe the most important point: collagen loss in postmenopausal skin correlates with hormonal age, not chronological age. A woman who entered perimenopause at forty may have significantly less dermal collagen at fifty than a woman of the same age who entered it at fifty-two. This explains why two clients with identical sun histories and lifestyles can look noticeably different — the difference often isn't habits, it's hormonal timing.
Progesterone
Progesterone works in partnership with estrogen across the menstrual cycle and pregnancy. Its skin effects are more subtle but still relevant.
Progesterone supports fluid balance, modulates sebum production, and influences skin sensitivity and reactivity. It rises in the second half of the menstrual cycle (the luteal phase), which is why many clients experience predictable premenstrual changes — increased oiliness, breakouts (particularly along the jawline and chin), puffiness, and heightened sensitivity in the week before menstruation.
In pregnancy, sustained high progesterone (along with shifted estrogen and androgen patterns) contributes to both the famed "pregnancy glow" and the less-discussed flares of acne, melasma, and reactivity many pregnant clients experience.
Androgens (testosterone, DHEA, DHT)
Androgens are often called "male hormones," but they are present and active in all bodies. Women produce meaningful amounts of testosterone and its derivatives, and androgens are the primary driver of sebaceous gland activity. They are central to nearly all acne presentations.
Androgens stimulate sebaceous gland development and sebum production. They increase follicular keratinization (which contributes to clogged pores). They promote hair growth in androgen-sensitive areas. They also influence skin thickness.
When androgens are elevated, or when the skin is hypersensitive to normal androgen levels, the result is acne, oily skin, enlarged pores, and in some cases hirsutism — unwanted hair growth, typically on the jaw, chin, upper lip, or sideburn area.
This pattern is central to several presentations you will see often:
Polycystic Ovary Syndrome (PCOS). The most common endocrine disorder in women of reproductive age, characterized by androgen excess, insulin resistance, and frequently significant skin manifestations. PCOS-driven acne tends to be inflammatory, cystic, and concentrated along the jawline. It does not respond well to standard topical-only protocols because the root driver is internal.
Hormonal acne in adulthood. Often cyclical, inflammatory, and distributed along the lower face — chin, jawline, neck. A signature pattern that becomes recognizable once you know to look for it.
Menopause-related chin hair and jawline acne. As estrogen falls, the relative influence of androgens rises, even when absolute androgen levels decline. This produces the classic perimenopausal pattern of new chin hairs alongside renewed adult acne.
Cortisol
Cortisol is the body's primary stress hormone, produced by the adrenal glands. Acute cortisol release is essential and adaptive. Chronic elevation is damaging across virtually every system, including the skin.
Chronically elevated cortisol degrades collagen, impairs barrier function, suppresses wound healing, drives inflammation, disrupts sleep (which compounds the damage), and elevates blood sugar — which in turn accelerates glycation. Cortisol is the hormone that ties together stress, sleep, and skin most tightly, which is why we have spent two earlier posts in this series on stress and sleep specifically. They are not separate conversations from the hormonal conversation.
Insulin
Insulin is the hormone that regulates blood sugar. Its role in skin health is largely mediated through three pathways: inflammation, androgen metabolism, and glycation.
When insulin is dysregulated — chronically elevated, or with frequent spikes from high-glycemic eating — it increases IGF-1 (insulin-like growth factor 1), which directly stimulates sebum production and androgen activity. This is part of why high-glycemic diets so consistently worsen acne. Insulin dysregulation also drives glycation through elevated and variable blood sugar, contributing to the structural collagen damage discussed in the diet and gut post. And it contributes to chronic low-grade inflammation, which underlies almost every inflammatory skin condition we treat.
Thyroid hormones
The thyroid regulates cellular metabolism throughout the body, including in the skin. Both hypothyroidism (underactive) and hyperthyroidism (overactive) produce recognizable skin changes — and thyroid dysfunction is common, often undiagnosed, and frequently presents with skin changes before other symptoms become obvious.
Hypothyroidism often presents as dry, rough skin, slow cell turnover, puffiness (particularly periorbital), and skin that reads as cold, pale, or yellow-tinged. Hair may be thinning, brittle, or shedding more than usual.
Hyperthyroidism often presents as warm, flushed skin, increased sweating, thinner skin, and sometimes rapid changes in skin texture or oiliness.
Growth hormone and IGF-1
Growth hormone, released primarily during deep sleep, supports tissue repair and collagen synthesis throughout the body. It mediates many of its effects through IGF-1.
When growth hormone is low — from poor sleep, chronic stress, or age-related decline — the skin's repair capacity declines with it. This is part of why poorly slept clients show diminished returns from professional treatments and homecare alike.
When IGF-1 is elevated — from high dairy intake, high-glycemic eating, or insulin resistance — it directly stimulates sebum production and androgen activity, contributing to acne. This is the mechanism behind the well-established dairy-acne and high-glycemic-acne connections.
The hormonal arc across a lifetime
The skin's hormonal story is not static. It shifts predictably across life stages, and understanding these patterns helps us anticipate what is likely happening and why.
Puberty. Rising androgens stimulate sebaceous gland activity, producing the characteristic oiliness and inflammatory acne of adolescence. Skin is typically resilient and heals well, supported by high estrogen, growth hormone, and cellular turnover rates.
Reproductive years (late teens through late thirties). Estrogen and progesterone cycle monthly, producing predictable skin fluctuations — oilier and more reactive premenstrually, clearer and more hydrated around ovulation. Collagen levels are well-supported. Most clients in this stage have the greatest skin resilience of their lives. This is also the stage where most skincare is marketed and most expectations are set, which becomes a problem later.
Pregnancy. Dramatic hormonal shifts can produce the "pregnancy glow" (increased blood flow and hydration), melasma (pigmentation driven by estrogen and progesterone), acne flares, and vascular changes. Postpartum involves another major hormonal shift, often accompanied by acne, hair loss, and significant skin changes that can persist for months.
Perimenopause (typically mid-forties to early fifties). This is often where skin changes accelerate most dramatically — and most confusingly for clients. Estrogen and progesterone begin to fluctuate wildly before declining. Clients frequently present with adult-onset acne, increasing dryness, loss of elasticity, new sensitivity, and the disorienting experience of their skin no longer responding to products that used to work. Perimenopause can actually feel worse than the more stable postmenopausal state in one important way: estrogen does not decline smoothly, it fluctuates chaotically, and the skin reflects that chaos.
Menopause. After estrogen has fully declined, collagen loss is rapid in the first few years — that 30% in the first five years figure. Skin becomes thinner, drier, less elastic, and more prone to damage. The structural support that estrogen provided is permanently reduced without hormone replacement therapy.
Post-menopause and aging. Skin continues to lose collagen at a slower rate, along with elastin, hyaluronic acid, and barrier function. Repair capacity declines. Lifetime UV damage and accumulated oxidative stress become more visible. The skin in this stage requires fundamentally different support than it did even a decade earlier.
What this means in the treatment room
A few practical shifts that come from integrating hormonal awareness into your practice.
Hormonal acne does not respond to skincare the way comedonal acne does. A client with PCOS-driven cystic jawline acne will get frustrated with standard acne protocols because the root driver is not being addressed topically. Recognizing the pattern prevents over-treatment, prevents barrier damage from aggressive protocols, and helps you set accurate expectations from the start.
Perimenopause is an underserved client population. Many women in their forties and early fifties are navigating dramatic skin changes without adequate support — from their dermatologists, from their providers, from their estheticians. Being able to name what is happening, explain why, and design protocols specifically for changing skin is professionally valuable and personally meaningful to these clients. They will become some of your most loyal clients, because no one else has explained their skin to them honestly.
Hormonal skin requires different product strategies at different life stages. The protocol that served a client beautifully at thirty-five will often fail her at forty-eight. Over-exfoliation, barrier disruption, and aggressive actives become increasingly problematic as estrogen declines. Barrier support, peptide and growth factor support, gentler delivery systems, and careful pacing become more important. This is also where K-beauty's barrier-first philosophy genuinely shines for the perimenopausal and menopausal client — it was built for exactly this kind of careful, layered support.
Referral is frequently warranted. PCOS, thyroid dysfunction, insulin resistance, and menopause management are medical conversations. An esthetician who recognizes the pattern and points the client toward her physician, an endocrinologist, or a functional medicine practitioner is providing better care than one who tries to handle it all topically.
Cortisol and stress are in the conversation whether you name them or not. A client who is under chronic stress will have skin that underperforms regardless of the protocol. Asking about stress load, sleep quality, and lifestyle is not outside our scope — it is part of holistic care.
Intake should include hormonal context. Asking about menstrual cycle regularity, pregnancy and postpartum history, menopausal status, and any diagnosed hormonal conditions is clinical intake, not personal intrusion. It provides essential context for treatment planning, and most clients are relieved to have an esthetician who actually wants to know.
The skin can be an early signal. For some clients, the first sign of a hormonal shift — thyroid dysfunction, insulin resistance, perimenopause — appears in the skin before other symptoms become apparent. An esthetician who can recognize these patterns can encourage clients to seek appropriate medical evaluation earlier than they otherwise would. This is not overstepping, it is good professional practice.
The conversation to have with your client
Most clients have never had an honest, specific conversation about how their hormones are shaping their skin. They have been given vague references to "hormonal acne" or "menopausal skin" without much explanation of what is actually happening or why their products stopped working.
You can say something like:
"Some of the things you've mentioned makes me wonder if there is a hormonal component involved. The good news is this gives us a lot of information about what your skin actually needs. The harder truth is that skincare products alone won't fully address it — the root is internal. We're going to focus on supporting your barrier, calming inflammation, and giving your skin the structural support it's missing, and I'd also encourage you to have a conversation with your physician. The combination of internal support and the right products/treatments is what will actually move the needle for you."
The broader point
Hormones are one of the most significant systemic inputs to skin appearance and function, and they operate largely outside of what topical products can address.
This does not mean topical care is irrelevant. Good skincare is essential, and certain ingredients and strategies are specifically supportive of hormonally challenged skin — peptides, growth factors, barrier-supportive lipids, gentle exfoliation, well-formulated antioxidants, and increasingly, ingredients that target estrogen-deficient skin specifically.
But pretending skincare alone can override a hormonal imbalance is a professional error that leads to frustrated clients, damaged barriers, and suboptimal outcomes. Our role is not to diagnose. It is to recognize patterns, provide appropriate treatments, give thoughtful homecare recommendations, and refer when medical support is warranted.
This is the essence of holistic skincare: understanding that internal and external both matter, and that the best outcomes come from treating the skin as part of the whole system it is embedded in. Hormones are one of the most powerful expressions of that system.
Sources:
Brincat M, et al. A study of the decrease of skin collagen content, skin thickness, and bone mass in the postmenopausal woman. PubMed, 1987. https://pubmed.ncbi.nlm.nih.gov/3120067/
Archer DF. Postmenopausal skin and estrogen. Reviewed in Stevenson S, Thornton J. Effect of estrogens on skin aging and the potential role of SERMs. Clinical Interventions in Aging, 2007.
Estrogen-deficient skin: The role of topical therapy. International Journal of Women's Dermatology, 2019. https://www.sciencedirect.com/science/article/pii/S2352647519300012
Menopause, skin and common dermatoses. Part 2: skin disorders. Clinical and Experimental Dermatology, 2022. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092853/
Managing Menopausal Skin Changes: A Narrative Review of Skin Quality Changes, Their Aesthetic Impact, and the Actual Role of Hormone Replacement Therapy in Improvement. PMC, 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12374573/
Phytoestrogens as Natural Anti-Aging Solutions for Enhanced Collagen Synthesis in Skin. PMC, 2025. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11845927/




